about
Pathogenesis and disease mechanisms of occupational asthmaType 2 innate lymphoid cells: at the cross-roads in allergic asthmaCritical role of actin-associated proteins in smooth muscle contraction, cell proliferation, airway hyperresponsiveness and airway remodelingDeciphering Asthma Biomarkers with Protein Profiling TechnologyTargeted anti-inflammatory therapeutics in asthma and chronic obstructive lung diseaseRegulation of STATs by polycystin-1 and their role in polycystic kidney diseaseIL-4 and IL-13 signaling in allergic airway diseaseThe role of type 2 innate lymphoid cells in asthmaTargeting EGFR signalling in chronic lung disease: therapeutic challenges and opportunitiesAllergen uptake, activation, and IL-23 production by pulmonary myeloid DCs drives airway hyperresponsiveness in asthma-susceptible miceMolecular Basis for Shared Cytokine Recognition Revealed in the Structure of an Unusually High Affinity Complex between IL-13 and IL-13Rα2Mechanisms underlying helper T-cell plasticity: implications for immune-mediated disease.Instructive roles for cytokine-receptor binding parameters in determining signaling and functional potencyBiologics in asthma--the next step toward personalized treatmentMonoclonal antibodies and other biologic agents in the treatment of asthmaMetal oxide nanoparticles induce unique inflammatory footprints in the lung: important implications for nanoparticle testingAnti-malarial drug artesunate attenuates experimental allergic asthma via inhibition of the phosphoinositide 3-kinase/Akt pathwayCD300f associates with IL-4 receptor α and amplifies IL-4-induced immune cell responsesDevelopment of pre-clinical models for evaluating the therapeutic potential of candidate siRNA targeting STAT6Respiratory Syncytial Virus: Infection, Detection, and New Options for Prevention and Treatment.IL-13-induced proliferation of airway epithelial cells: mediation by intracellular growth factor mobilization and ADAM17TRPA1-dependent pruritus in IL-13-induced chronic atopic dermatitis.Allergen challenge induces Ifng dependent GTPases in the lungs as part of a Th1 transcriptome response in a murine model of allergic asthma.Beta-escin has potent anti-allergic efficacy and reduces allergic airway inflammation.Additive effect between IL-13 polymorphism and cesarean section delivery/prenatal antibiotics use on atopic dermatitis: a birth cohort study (COCOA).Stigmasterol Modulates Allergic Airway Inflammation in Guinea Pig Model of Ovalbumin-Induced Asthma.Neutralisation of interleukin-13 in mice prevents airway pathology caused by chronic exposure to house dust mite.A randomized controlled trial to evaluate inhibition of T-cell costimulation in allergen-induced airway inflammation.Eosinophils and allergic airway disease: there is more to the storyAirway wall expression of OX40/OX40L and interleukin-4 in asthmaReduced FcepsilonRI-mediated release of asthma-promoting cytokines and chemokines from human basophils during omalizumab therapy.Novel approach to inhibit asthma-mediated lung inflammation using anti-CD147 intervention.Small molecule analogues of the immunomodulatory parasitic helminth product ES-62 have anti-allergy propertiesInterleukin (IL)-4 and IL-13 up-regulate monocyte chemoattractant protein-1 expression in human bronchial epithelial cells: involvement of p38 mitogen-activated protein kinase, extracellular signal-regulated kinase 1/2 and Janus kinase-2 but not c-JAssociations of IL-4, IL-4R, and IL-13 gene polymorphisms in coal workers' pneumoconiosis in China: a case-control study.Airway delivery of soluble factors from plastic-adherent bone marrow cells prevents murine asthma.Activation-induced cytidine deaminase (AID)-associated multigene signature to assess impact of AID in etiology of diseases with inflammatory component.MiR-375 is downregulated in epithelial cells after IL-13 stimulation and regulates an IL-13-induced epithelial transcriptome.Interleukin-13-induced mucous metaplasia increases susceptibility of human airway epithelium to rhinovirus infection.Neuroimmune semaphorin 4A as a drug and drug target for asthma
P2860
Q23924178-33C07C5C-E36A-4E29-9B8A-3B09CCBCC646Q26766464-48AB5B5D-6B6A-4B2E-A90A-EBC3CDCE191CQ26777713-9FBD022D-8AC7-4BF5-A84C-10791C31BBD2Q26783095-C88E8155-52AA-4CCF-BBE9-7C971FC801EEQ26786229-300868A4-A06F-4CA5-AAF4-A827F8B6DBC7Q26852136-E1544029-0D5A-4F4D-B548-DFCEAD07058CQ26859510-FAFEEE87-F106-43B0-91CE-D3EF0317BAA0Q26995991-33500EB2-D0DE-4103-87AA-5C6554FB16F4Q27027433-8C561573-51D5-4663-B17F-FB1ACAD6DD1DQ27438135-879D6CEF-1821-4B1A-9F04-0EF3FE7EA367Q27660192-1865BDD6-A2F5-417C-9CD3-7715776032F8Q27687830-CF8E8A0C-A706-4FC4-8147-38B0C5806F0FQ27702599-972E97F7-3821-45E2-BF29-88956CBD8796Q28085614-1404AC9F-306A-44DD-878D-D37477C2122FQ28270037-7D00B7B3-3576-4775-829E-4D9A93FDABE0Q28385263-C5D82CED-5EA8-4FA1-8201-0848FDAA997AQ28478508-6EA742E9-AB11-4C59-B309-2D1720031705Q28509921-2B42F008-FFF4-4F69-9113-C3664E321D3DQ28540216-12961A7E-CD33-4391-8777-87EA78CE10DCQ30240274-D0F82B43-1C34-44C7-9C52-FDF621AD7F32Q30480054-E50FD0A1-BF33-4699-997C-80412F053040Q30587902-070991B8-EFFB-4B21-9FCD-FD4EAB31D0E6Q33520235-A2D53417-6DCA-46FA-9F6F-B9135AB4CFC6Q33582849-E2C3CE23-B78B-46CA-977A-5F53572CFDD4Q33644355-86F7D46C-52C4-494F-838A-1C2E549D2A6CQ33710508-7BF6018E-E585-438A-9789-A34F716E92C3Q33722148-B19B2180-0BAC-4F6F-8EA4-D7ADD0A6E361Q33738516-AF1A250A-1597-4C02-B122-5F5243BAFA5EQ33756427-0EE2C3A2-72F7-4D82-95E5-A5DB7C671F2EQ33776845-C9639DF7-B7D4-4EC7-9F56-7BB543B19FEFQ33785112-41481A71-C6BE-45A0-8E90-DBED905C6681Q33792231-B38BD423-8D33-4FD2-9E2B-B970E22F18DEQ33994121-E411BBA8-6ADD-4344-9FAC-00726341582EQ33997038-F6066050-CC33-439E-8034-989622B894F4Q33998935-6A608E88-3A16-4F7C-B6CC-D4F4532DA232Q34014379-3D02401A-4B41-4B4D-B81B-8842377D1FC5Q34044904-6F756695-D704-4F86-8A71-5ECC101C87B5Q34131643-05AE475C-F233-44D9-889B-364242CE3E0CQ34357091-B5AAB1F9-E756-45B1-9D58-7B780D81B501Q34367862-D24DC870-F2EB-4B6E-B4C2-E24B6F18EBA5
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Interleukin-13 in asthma pathogenesis.
@en
Interleukin-13 in asthma pathogenesis.
@nl
type
label
Interleukin-13 in asthma pathogenesis.
@en
Interleukin-13 in asthma pathogenesis.
@nl
prefLabel
Interleukin-13 in asthma pathogenesis.
@en
Interleukin-13 in asthma pathogenesis.
@nl
P1476
Interleukin-13 in asthma pathogenesis.
@en
P2093
Marsha Wills-Karp
P304
P356
10.1111/J.0105-2896.2004.00215.X
P577
2004-12-01T00:00:00Z